Jagmeet Sohal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jagmeet Sohal has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Saksham Sood
Centre of Research Impact and Outcome, Chitkara University, Rajpura- 140417, Punjab, India
2 shared publications - Dhairyasheel D. Patil
Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed to be University”, Dept. of Medicine, Taluka-Karad, Dist-Satara, Maharashtra, India
1 shared publication - Divya Sharma
Centre of Research Impact and Outcome, Chitkara University, Rajpura- 140417, Punjab, India
1 shared publication - Harsh Bhati
Noida International University, Department of General Surgery, Greater Noida, Uttar Pradesh, India
1 shared publication - Jennifer D.
Department of CSE, Panimalar Engineering College, TamilNadu, India
1 shared publication - Jitendra Narayan Senapati
Department of General Surgery, IMS and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1591
Current Approaches for Reducing Treatment Toxicities in Radiotherapy Side Effects Management
Radiotherapy is an important part of treating many types of cancer because it targets and kills cancerous cells. But even though it works well as a treatment, it often has bad side effects because it exposes good cells around the tumor to radiation without meaning to. These side effects can be very harmful during treatment, lowering the quality of life for the patient and maybe even making it harder to give the tumor the right amount of radiation. Recent improvements in radiation treatments and ways to deal with side effects have focused on reducing these harmful effects while keeping the treatment effective. One important way to lower the side effects of radiotherapy is to improve the way the treatment is given. Different methods, like intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and proton therapy, make it possible to give radiation more precisely, protecting good cells around the tumor from too much exposure. These methods use high-tech imaging methods and complex computer programs to precisely target tumors and lower the risk of side effects. Using tailored radiation, which takes into account changes in the body and anatomy during treatment, makes treatment even more accurate. Along with improvements in technology, a multidisciplinary approach to managing toxins has become more important. Combining drug treatments, like radioprotectors and tailored therapies, has been looked into as a way to lessen the damage that radiation does to healthy cells. The goal of these chemicals is to protect healthy cells from radiation damage while not affecting the treatment of cancer cells. Biomarker-based methods are also making it easier to predict and customize treatment plans.
- 29 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1591
Open AccessCurrent Approaches for Reducing Treatment Toxicities in Radiotherapy Side Effects Management
Radiotherapy is an important part of treating many types of cancer because it targets and kills cancerous cells. But even though it works well as a treatment, it often has bad side effects because it exposes good cells around the tumor to radiation without meaning to. These side effects can be very harmful during treatment, lowering the quality of life for the patient and maybe even making it harder to give the tumor the right amount of radiation. Recent improvements in radiation treatments and ways to deal with side effects have focused on reducing these harmful effects while keeping the treatment effective. One important way to lower the side effects of radiotherapy is to improve the way the treatment is given. Different methods, like intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and proton therapy, make it possible to give radiation more precisely, protecting good cells around the tumor from too much exposure. These methods use high-tech imaging methods and complex computer programs to precisely target tumors and lower the risk of side effects. Using tailored radiation, which takes into account changes in the body and anatomy during treatment, makes treatment even more accurate. Along with improvements in technology, a multidisciplinary approach to managing toxins has become more important. Combining drug treatments, like radioprotectors and tailored therapies, has been looked into as a way to lessen the damage that radiation does to healthy cells. The goal of these chemicals is to protect healthy cells from radiation damage while not affecting the treatment of cancer cells. Biomarker-based methods are also making it easier to predict and customize treatment plans.
- Open Access
- 6 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 636
The role of Surgery in the treatment of spinal Dural Arteriovenous fistula
The vascular abnormality known as a spinal dural arteriovenous fistula (SDAVF) is highly uncommon. To perceive the anomaly, the gold standard before surgical operations like vascular therapy or open surgical procedures involves computerized reduction imaging. Hidden SDAVFs on an angiogram have been documented before. There was no assessment of surgical options for SDAVFs with false-positive angiogram findings. Patients who underwent SDAVF surgery in 2018–2019 at a single institution had their medical records, and imaging trainings revised retrospectively. After failing endovascular embolization or worsening clinically and radiographically in the context of an angiographically hidden lesion, all patients were referred for surgical intervention. Surgery options for these lesions were explored after a thorough case assessment. There was a total of 4 cases in this series. Despite undergoing embolization before surgical repair, the neurological status of 2 patients deteriorated further, while embolization in 2 other patients was unsuccessful due to the complexity of their vascular systems. All four patients had their neurological conditions improve or remain stable after the examination. Microscopically integrated fluorescence angiography with indocyanine green injection helped identify the supplier’s veins and proved the SDAVF closure. After an SDAVF has been identified, immediate treatment is necessary. If angiography results are unclear or raise doubts about the presence of SDAVF, an urgent spinal investigation should be performed. Indocyanine exploring spine surgery for SDAVF completion may benefit from green light micro angiography.
- 6 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 636
Open AccessThe role of Surgery in the treatment of spinal Dural Arteriovenous fistula
The vascular abnormality known as a spinal dural arteriovenous fistula (SDAVF) is highly uncommon. To perceive the anomaly, the gold standard before surgical operations like vascular therapy or open surgical procedures involves computerized reduction imaging. Hidden SDAVFs on an angiogram have been documented before. There was no assessment of surgical options for SDAVFs with false-positive angiogram findings. Patients who underwent SDAVF surgery in 2018–2019 at a single institution had their medical records, and imaging trainings revised retrospectively. After failing endovascular embolization or worsening clinically and radiographically in the context of an angiographically hidden lesion, all patients were referred for surgical intervention. Surgery options for these lesions were explored after a thorough case assessment. There was a total of 4 cases in this series. Despite undergoing embolization before surgical repair, the neurological status of 2 patients deteriorated further, while embolization in 2 other patients was unsuccessful due to the complexity of their vascular systems. All four patients had their neurological conditions improve or remain stable after the examination. Microscopically integrated fluorescence angiography with indocyanine green injection helped identify the supplier’s veins and proved the SDAVF closure. After an SDAVF has been identified, immediate treatment is necessary. If angiography results are unclear or raise doubts about the presence of SDAVF, an urgent spinal investigation should be performed. Indocyanine exploring spine surgery for SDAVF completion may benefit from green light micro angiography.
- Open Access
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 536
Diagnostic and Prognostic Value of Liquid Biopsies in Non-Invasive Cancer Monitoring
Researchers are finding that liquid biopsies, which are samples of blood, saliva, or pee that are not solid, can be used to find biomarkers that can help diagnose and track cancer. Traditional tissue biopsies are invasive and may not always be possible. Liquid biopsies, on the other hand, can be used over and over again and in real time to find genetic changes linked to cancer, differences in tumors, and treatment reactions. This piece talks about the diagnostic and predictive worth of liquid samples in cancer care. It focuses on how they can help with early diagnosis, tracking the development of the disease, figuring out the minimal residual disease (MRD), and guessing how well treatment will work. A liquid biopsy has gotten a lot of attention as an early cancer screening method because it can find genetic changes early on, often before any signs show up. It is possible to find cancer-related changes in cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs) using liquid samples. This information can help with early action and specific treatment plans. Liquid biopsies also show differences between tumors and how genes change over time, which is very important for figuring out how drug resistance works. Liquid biopsy has been very helpful for figuring out how well treatment is working and finding relapses. Monitoring ctDNA levels in real time can show how much of a tumor there is, which lets doctors see how well treatment is working and make changes to treatment plans as required. The amount and prevalence of ctDNA have been linked to tumor growth, showing an early sign of recurrence even before regular imaging methods show disease that can be seen by a doctor.
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 536
Open AccessDiagnostic and Prognostic Value of Liquid Biopsies in Non-Invasive Cancer Monitoring
Researchers are finding that liquid biopsies, which are samples of blood, saliva, or pee that are not solid, can be used to find biomarkers that can help diagnose and track cancer. Traditional tissue biopsies are invasive and may not always be possible. Liquid biopsies, on the other hand, can be used over and over again and in real time to find genetic changes linked to cancer, differences in tumors, and treatment reactions. This piece talks about the diagnostic and predictive worth of liquid samples in cancer care. It focuses on how they can help with early diagnosis, tracking the development of the disease, figuring out the minimal residual disease (MRD), and guessing how well treatment will work. A liquid biopsy has gotten a lot of attention as an early cancer screening method because it can find genetic changes early on, often before any signs show up. It is possible to find cancer-related changes in cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs) using liquid samples. This information can help with early action and specific treatment plans. Liquid biopsies also show differences between tumors and how genes change over time, which is very important for figuring out how drug resistance works. Liquid biopsy has been very helpful for figuring out how well treatment is working and finding relapses. Monitoring ctDNA levels in real time can show how much of a tumor there is, which lets doctors see how well treatment is working and make changes to treatment plans as required. The amount and prevalence of ctDNA have been linked to tumor growth, showing an early sign of recurrence even before regular imaging methods show disease that can be seen by a doctor.
- Open Access
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 524
Myofibroblast Activity in Diabetic Wound Healing: Unravelling the Diabetes Connection and Therapeutic Interventions
BDiabetic wound healing poses a significant clinical challenge due to the impaired regenerative capacity observed in individuals with diabetes. Diabetes causes a dysregulated wound healing process that is multidimensional and involves intricate interactions between cellular and molecular processes. This paper reviews discuss the activity of myofibroblasts in the context of diabetic wound healing. Myofibroblasts are specialized cells with contractile capabilities that are essential for developing scars and tissue healing. They are one of the main participants in this complex process. Wound healing is a multifaceted and ever-changing biological response involving several interrelated systems. Enzymes responsible for the control of the extracellular matrix (ECM) are tissue inhibitors of metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs). The ECM is essential for wound healing, reconstruction of tissues, and other bodily processes. Diabetes and myofibroblast apoptosis have a complicated and multidimensional interaction. Diabetes is a chronic illness that needs to be managed continuously since it fails to go away on the own. This strategy has strained interest in a number of areas, including wound healing. Certain academics have looked at the possibility of repurposing medications for wound care applications, even if this could not be typical. Dipeptidyl peptidase 4, metformin, and propranolol are used in the reusing of medications for the purpose of promoting wound healing. This review provides information on the influence of diabetes on myofibroblast function and fibroblast differentiation, as well as potential treatment options associated with the affected pathways.
- 31 December 2024
- Published by Salud, Ciencia y Tecnologia in Seminars in Medical Writing and Education
- Vol. 3, 524
Open AccessMyofibroblast Activity in Diabetic Wound Healing: Unravelling the Diabetes Connection and Therapeutic Interventions
BDiabetic wound healing poses a significant clinical challenge due to the impaired regenerative capacity observed in individuals with diabetes. Diabetes causes a dysregulated wound healing process that is multidimensional and involves intricate interactions between cellular and molecular processes. This paper reviews discuss the activity of myofibroblasts in the context of diabetic wound healing. Myofibroblasts are specialized cells with contractile capabilities that are essential for developing scars and tissue healing. They are one of the main participants in this complex process. Wound healing is a multifaceted and ever-changing biological response involving several interrelated systems. Enzymes responsible for the control of the extracellular matrix (ECM) are tissue inhibitors of metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs). The ECM is essential for wound healing, reconstruction of tissues, and other bodily processes. Diabetes and myofibroblast apoptosis have a complicated and multidimensional interaction. Diabetes is a chronic illness that needs to be managed continuously since it fails to go away on the own. This strategy has strained interest in a number of areas, including wound healing. Certain academics have looked at the possibility of repurposing medications for wound care applications, even if this could not be typical. Dipeptidyl peptidase 4, metformin, and propranolol are used in the reusing of medications for the purpose of promoting wound healing. This review provides information on the influence of diabetes on myofibroblast function and fibroblast differentiation, as well as potential treatment options associated with the affected pathways.
- Open Access
- 30 December 2024
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .396
Bariatric Surgery and Pregnancy: Impact on Maternal and Fetal Health
To contrast the prenatal results of female patients prior to and following weight-loss surgery giving birth. Methods: a review of the literature was conducted at a hospital to examine the prenatal results of women who gave birth before and after having weight loss procedure. To account for confounders, a model with multiple logistic regression variables was created. Findings: 301 deliveries occurred before and 507 occurred after weight loss surgery across the research period. Following the procedure, there was a notable decrease in the incidence of fetal obesity , hypertensive diseases , and metabolic syndrome . The results indicated that there was an independent link between bariatric surgery and a decrease in the incidence of hypertension , diabetes mellitus , and macros- . Bariatric surgery before pregnancy can enhance maternal health, though it must be carefully monitored to avoid nutritional deficits. Optimal prenatal care is critical for both fetal growth and maternal health.
- 30 December 2024
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 3, .396
Open AccessBariatric Surgery and Pregnancy: Impact on Maternal and Fetal Health
To contrast the prenatal results of female patients prior to and following weight-loss surgery giving birth. Methods: a review of the literature was conducted at a hospital to examine the prenatal results of women who gave birth before and after having weight loss procedure. To account for confounders, a model with multiple logistic regression variables was created. Findings: 301 deliveries occurred before and 507 occurred after weight loss surgery across the research period. Following the procedure, there was a notable decrease in the incidence of fetal obesity , hypertensive diseases , and metabolic syndrome . The results indicated that there was an independent link between bariatric surgery and a decrease in the incidence of hypertension , diabetes mellitus , and macros- . Bariatric surgery before pregnancy can enhance maternal health, though it must be carefully monitored to avoid nutritional deficits. Optimal prenatal care is critical for both fetal growth and maternal health.